BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/21/2026 7:21:41 AM | Browse: 3 | Download: 0
 |
Received |
|
2026-05-14 07:28 |
|
Peer-Review Started |
|
2026-05-14 07:28 |
|
First Decision by Editorial Office Director |
|
2026-05-19 02:08 |
|
Return for Revision |
|
2026-05-19 02:08 |
|
Revised |
|
2026-06-03 06:16 |
|
Publication Fee Transferred |
|
2026-06-04 12:03 |
|
Second Decision by Editor |
|
2026-06-26 02:16 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-06-26 07:42 |
|
Articles in Press |
|
2026-06-26 07:42 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-15 09:40 |
|
Publish the Manuscript Online |
|
2026-07-21 07:21 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pediatrics |
| Manuscript Type |
Case Report |
| Article Title |
Fish oil emulsion for reversal of intestinal failure-associated liver disease in preterm infants: Three case reports and review of literature
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hong-Ju Chen, Zhuo-Ga Danzeng, Peng-Fei Ye, Xiao-Ming Xu, Juan Liang and Li Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Clinical research funding of West China Second University Hospital, Sichuan University |
KL073 |
| National Natural Science Foundation of China (General Program) |
81501304 |
|
| Corresponding Author |
Juan Liang, Department of Pediatrics, West China Second University Hospital, Sichuan University, No. 20 Section 3, Renmin South Road, Wuhou District, Chengdu 610041, Sichuan Province, China. liangjuan079@163.com |
| Key Words |
Intestinal failure-associated liver disease; Fish oil lipid emulsion; Parenteral nutrition; Preterm infants; Case report |
| Core Tip |
Prolonged parenteral nutrition in preterm infants can lead to intestinal failure-associated liver disease (IFALD). We describe three preterm infants with severe IFALD who were treated with pure fish oil lipid emulsion (FO-ILE) at 2 g/kg/day—higher than conventional protocols. This approach was associated with a rapid decline in direct bilirubin levels and was well tolerated without evidence of essential fatty acid deficiency, growth impairment, or bleeding complications. To the best of our knowledge, this report is among the first reports of high-dose FO-ILE for severe IFALD in preterm infants, a vulnerable population because of hepatic immaturity. |
| Publish Date |
2026-07-21 07:21 |
| Citation |
Chen HJ, Danzeng ZG, Ye PF, Xu XM, Liang J, Zhang L. Fish oil emulsion for reversal of intestinal failure-associated liver disease in preterm infants: Three case reports and review of literature. World J Clin Cases 2026; 14(21): 123291
|
| URL |
https://www.wjgnet.com/2307-8960/full/v14/i21/123291.htm |
| DOI |
https://doi.org/10.12998/wjcc.123291 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
